CD68 and glioblastoma: In addition, the high expression of CD68 was related to an unfavorable DSS in KIRC (HR 1.04, 95% CI 1.02–1.07, P = 0.0052), GBM (HR 1.05, 95% CI 1.00–1.10, P = 0.0490), LGG (HR 1.19, 95% CI 1.06–1.34, P = 0.0410), and THYM (HR 1.69, 95% CI 1.04–2.77, P = 0.0360) (Fig. 3B and Supplementary Fig. 1C–I).